Nicholas Piramal to launch anti-cancer drug

Pharma major Nicholas Piramal, which recently announced that it will hive off its new chemical entities (NCE) R&D division into a separate company, is planning to launch an anti-cancer drug by 2010.
“We have three molecules in the clinical trial stage in the anti-cancer, anti-inflammatory and anti-infectives segment. Among the three, we hope to launch the anti-cancer drug by 2010, “ Nicholas Piramal’s director strategic alliance and communications, Swati Piramal said. The company has received the US Foods and Drugs Administration approval and is conducting clinical trials of the molecule in India and Canada.